510(k) K200009
- Device
- Adaptive Biotechnologies ClonoSEQ Assay
- Applicant
- Adaptive Biotechnologies Corporation
- 510(k) number
- K200009
- Product code
- QDC
- Decision
- Substantially Equivalent (SESE)
- Decision date
- 2020-08-05
- Date received
- 2020-01-02
- Regulation
- 866.6100
- Classification name
- Dna-based Test For Minimal Residual Disease For Hematologic Malignancies
- Medical specialty
- Pathology
- Review panel
- Molecular Genetics
- Device class
- 2
- Clearance type
- Traditional
- Statement or summary
- Summary
- Third party reviewed
- No
Applicant Contact#
- Contact
- Megan Duncan
- Address
- 1551 Eastlake Ave. E., Suite 200 Seattle WA US 98102 98102
FDA Registration Numbers#
- 3009879426
- 3004530258
- 3016838963
- 3019895551
Source Documents#
Other 510(k) Records For Product Code QDC #
| 510(k) | Device | Applicant | Decision date |
|---|---|---|---|
| DEN170080 | Adaptive Biotechnologies clonoSEQ Assay | Adaptive Biotechnologies Corporation | 2018-09-28 |
Legacy Summary#
Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links Follow FDA En Español Home Food Drugs Medical Devices Radiation-Emitting Products Vaccines, Blood & Biologics Animal & Veterinary Cosmetics Tobacco Products FDA Home Medical Devices Databases
FDA Review#
Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links Follow FDA En Español Home Food Drugs Medical Devices Radiation-Emitting Products Vaccines, Blood & Biologics Animal & Veterinary Cosmetics Tobacco Products FDA Home Medical Devices Databases